As we prepare for a future with more caregivers and more complex patient needs, let’s commit to valuing the care that happens ...

At the 6-month anniversary of the inauguration in January, The American Journal of Managed Care® looks back at the changes ...

Panelists discuss the significant disparities in hidradenitis suppurativa diagnosis and care, emphasizing the impact of race, ...

Panelists discuss how the evaluation process must evolve to accommodate therapies that show benefits in slowing atrophy and ...

Panelists discuss the vital role of multidisciplinary collaboration, provider education, and technology integration in ...

New data show midkine expression is heightened in small cell lung cancer, suggesting the growth factor may be an important ...

TP53 mutations can have a significant impact on the prognosis of diseases like chronic lymphocytic leukemia, but their effect ...

The FDA’s approval of linvoseltamab for adults with heavily pretreated relapsed/refractory multiple myeloma marks a significant advance, with Sundar Jagannath, MBBS, emphasizing its high response ...

Michael Hassett, MD, MPH, Dana-Farber Cancer Institute, reflects on the impact of HER2 identification on the breast cancer ...

Culturally informed, patient-centered strategies are needed to address acne and hyperpigmentation in patients with skin of color.

The CRL was given because the FDA did not consider the phase 1/2 IGNYTE trial to be an adequate and well-controlled clinical ...

New data highlight efficacy, safety, and time off treatment with as-needed ruxolitinib cream in pediatric atopic dermatitis.